» Articles » PMID: 31648295

Letter to the Editor

Overview
Journal Neuro Oncol
Specialties Neurology
Oncology
Date 2019 Oct 25
PMID 31648295
Authors
Affiliations
Soon will be listed here.
References
1.
Kleinschmidt-DeMasters B, Mulcahy Levy J . H3 K27M-mutant gliomas in adults vs. children share similar histological features and adverse prognosis. Clin Neuropathol. 2018; 37 (2018)(2):53-63. PMC: 5822176. DOI: 10.5414/NP301085. View

2.
Schreck K, Ranjan S, Skorupan N, Bettegowda C, Eberhart C, Ames H . Incidence and clinicopathologic features of H3 K27M mutations in adults with radiographically-determined midline gliomas. J Neurooncol. 2019; 143(1):87-93. PMC: 6482123. DOI: 10.1007/s11060-019-03134-x. View

3.
Lopez G, Oberheim Bush N, Berger M, Perry A, Solomon D . Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma. Acta Neuropathol Commun. 2017; 5(1):38. PMC: 5433088. DOI: 10.1186/s40478-017-0440-x. View

4.
Louis D, Giannini C, Capper D, Paulus W, Figarella-Branger D, Lopes M . cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol. 2018; 135(4):639-642. DOI: 10.1007/s00401-018-1826-y. View

5.
Khuong-Quang D, Buczkowicz P, Rakopoulos P, Liu X, Fontebasso A, Bouffet E . K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 2012; 124(3):439-47. PMC: 3422615. DOI: 10.1007/s00401-012-0998-0. View